Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A8OV
|
||||
| Former ID |
DNC005912
|
||||
| Drug Name |
N-acetyl-phenylalanyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Formula |
C13H15N3O2
|
||||
| Canonical SMILES |
CC(=O)NC(CC1=CC=CC=C1)C(=O)NCC#N
|
||||
| InChI |
1S/C13H15N3O2/c1-10(17)16-12(13(18)15-8-7-14)9-11-5-3-2-4-6-11/h2-6,12H,8-9H2,1H3,(H,15,18)(H,16,17)/t12-/m0/s1
|
||||
| InChIKey |
ITHLBMBCVIAAIX-LBPRGKRZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | Inhibitor | [527885] | |
| Cathepsin L | Target Info | Inhibitor | [527885] | ||
| Cathepsin S | Target Info | Inhibitor | [527885] | ||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.